Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection

Vaccine

Volumn 19, Issue 9-10, 2000, Pages 1225-1231

  Caselli, Elisabetta ^a   Balboni, Pier Giorgio ^a   Incorvaia, Carlo ^a   Argnani, Rafaela ^a   Parmeggiani, Francesco ^a   Cassai, Enzo ^a   Manservigi, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

DNA immunization; HSV 1 vaccine; Ocular infection

Indexed keywords

DNA VACCINE; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENCEPHALITIS; EYE INFECTION; HERPES; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IMMUNITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRUS 1, HUMAN; HERPESVIRUS VACCINES; KERATITIS, HERPETIC; MALE; RABBITS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 0034623971     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00242-5     Document Type: Article

References (26)

1. Herpes simplex virus vaccines
2. Protection from herpes simplex virus type 1 lethal and latent infection by secreted recombinant glycoprotein B costitutively expressed in human cells with a BK episomal vector
3. Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein
4. Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation
5. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge
6. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization
7. Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs
8. Local periocular vaccination protects against eye disease more effectively than systemic vaccination following primary ocular herpes simplex virus infection in rabbits
9. Vaccine therapy for ocular herpes simplex virus (HSV) infection: Periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbits
10. Experimental keratitis in rabbits by human HSV-1 variants: Prevention and treatment
11. DNA vaccines
12. Broadening the approaches to developing more effective vaccines
13. Genetic immunization against herpes simplex virus
14. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection
15. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease
16. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease
17. DNA immunization against experimental genital herpes simplex virus infection
18. Antibody response and protection capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins
19. Immunization with a DNA expressing vector encoding the varicella zoster virus glycoprotein E (gE) gene via intramuscular and subcutaneous routes
20. Effect of route of vaccination with vaccinia expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection
21. Induction of immune response to bovine herpesvirus type 1 gD in passively immune mice after immunization with a DNA-based vaccine
22. Mucosal and systemic antibody responses to a C4/V3 construct following DNA vaccination of rabbits via the Peyer's patch
23. Protection of rabbits from viral challenge by gene gun-based intracutaneous vaccination with a combination of cottontail rabbit papillomavirus E1, E2, E6, and E7 genes
24. Intramuscular injection of plasmid DNA encoding cottontail rabbit papillomavirus E1, E2, E6 and E7 induces T cell-mediated but not humoral immune responses in rabbits
25. DNA immunization with HIV-1 tat mutated in the trans activation domain induces humoral and cellular immune responses against wild-type Tat
26. Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB1 induces a protective immune response against HSV-1 infection